Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR in Simple Phobia
NCT00872716Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Apr 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in specific phobia comparing Quetiapine XR with Placebo (2 arms). Primary endpoint: Visual Analogue Scale for Anxiety. Started Apr 2009; status: completed.
02
Drugs
quetiapine
03
Conditions
specific phobia
Beyond the preview
Go deeper on NCT00872716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872716.